Citius Oncology announces annual shareholder meeting

• Citius Oncology will hold its annual shareholder meeting in Cranford, New Jersey on Sept. 29, 2026.
• Shareholders will vote to elect three Class II directors for terms running through the 2029 annual meeting.
• Ballots also cover ratification of Wolf & Company as independent auditor for the fiscal year ending Sept. 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Citius Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-093757), on August 26, 2026, and is solely responsible for the information contained therein.